跳至主要内容
临床试验/NCT05402566
NCT05402566已完成不适用

MRI Assessment of Impaired Glucose Metabolism in Alzheimer's Disease

University of Aarhus1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2022年12月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
21
试验地点
1
主要终点
Deuterium Metabolic Imaging

研究概览

简要总结

Diseases of dementia are chronic, untreatable, and cause a massive burden of morbidity. In this proposal, we seek to tackle the problem of better, earlier, and more efficient diagnosis using deuterium metabolic imaging (DMI). The study is divided in two sub-studies: 1) optimization and simplification of DMI protocols, and 2) a cross-sectional study of DMI in Alzheimer's patients and healthy controls.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Deuterium Metabolic Imaging

时间窗: Up to 150 mins after 2H-glucose ingestion

Lactate/glx ratio in the posterior cingulum (sub-study 2).

次要结局

  • Deuterium Metabolic Imaging(Up to 150 mins after 2H-glucose ingestion)
  • FDG-PET from the records (sub study 2)(At time of Deuterium Metabolic Imaging)
  • Blood samples(Up to 150 mins after 2H-glucose ingestion)
  • Cognitive tests from the records (sub study 2)(At time of Deuterium Metabolic Imaging)
  • Cerebrospinal fluid biochemistry from the records (sub study 2)(At time of Deuterium Metabolic Imaging)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

MRI Assessment of Impaired Glucose Metabolism in... | 临床试验